Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of options granted to purchase common stock

v3.22.2
Stockholders Equity (Details) - Schedule of options granted to purchase common stock
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Schedule of options granted to purchase common stock [Abstract]  
Number of Options, Outstanding at the beginning of period 4,084,549
Weighted average exercise price, Outstanding at the beginning of period (in Dollars per share) | $ / shares $ 3.95
Aggregate intrinsic value, Outstanding at the beginning of period (in Dollars) | $ $ 671
Number of Options, Granted 1,504,000
Weighted average exercise price, Granted (in Dollars per share) | $ / shares $ 1.25
Number of Options, Forfeited (622,559)
Weighted average exercise price, Forfeited (in Dollars per share) | $ / shares $ 4.07
Number of Options, Exercised
Weighted average exercise price, Exercised (in Dollars per share) | $ / shares
Number of Options, Outstanding at the end of period 4,965,990
Weighted average exercise price, Outstanding at the end of period (in Dollars per share) | $ / shares $ 3.12
Aggregate intrinsic value, Outstanding at the end of period (in Dollars) | $ $ 1,196
Exercisable at the end of period 2,699,833
Number of Options, Weighted average remaining contractual life – years 7 years 2 months 26 days